A damning new report on surgical procedures has been published by the National Confidential Enquiry into Patient Outcome and Death (NCEPOD).
The All Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPG) has published its final report into botulinum toxin, dermal fillers and other aesthetic non-surgical cosmetic treatments today.
Evidence for the inquiry into non-surgical cosmetic procedures in the UK must be submitted to the All-Party Parliamentary Group on Beauty, Aesthetics and Wellbeing (APPG BAW) by July 17.
Specialist law firm Cosmetic Surgery Solicitors has teamed up with government-approved register of accredited practitioners, Save Face, to caution would-be patients about discounted injectable treatments.
The Royal Society for Public Health (RSPH) has partnered with the newly-established Qualification Council for Cosmetic Procedures (QCCP) to launch new aesthetic qualifications for healthcare professionals.
Healthcare Improvement Scotland (HIS) has confirmed in a Stakeholder meeting earlier this week that aesthetic nurses who own HIS-registered clinics can now legally stock prescription only medications (POMs) such as botulinum toxin and hyaluronidase on premises.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Xeomin® has received cosmetic approval from the US Food and Drug Administration (FDA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
The British Association of Aesthetic Plastic Surgeons (BAAPS) has launched a psychology course aimed at developing the psychological skills of surgeons.
Aesthetic product manufacturer BioScience GmbH has received the European Commission approved CE mark extension for all its hyaluronic acid based dermal filler ranges HYAcorp, Genefill and HYAprof.